Exchanges: NASDAQ | NYSE | XLON | AMS | ADS | TSE | BRU

Financial News Feed

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift…

Read more

We can judge whether Viking Therapeutics, Inc. (NASDAQ:VKTX) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There's no better way to get these firms' immense resources and analytical capabilities working for us than

Read more

Q1 2019 Viking Therapeutics Inc Earnings Call

Read more

VKTX earnings call for the period ending March 31, 2019.

Read more

Viking Therapeutics beats by $0.02
08:08pm, Thursday, 02'nd May 2019

Read more

Viking Therapeutics Inc. shares jumped 11 percent in early trading, on track to open at the highest in four months, after new results for the company’s experimental therapy for non-alcoholic fatty liver disease.

Read more

Viking's shares received a boost from a pair of catalysts last month.

Read more

As Biotechnology companies, Viking Therapeutics Inc. (NASDAQ:VKTX) and MorphoSys AG (NASDAQ:MOR) are our subject to contrast. And more specifically their profitability, analyst recommendations, instit

Read more

Svb Leerink upgraded shares of Viking Therapeutics (NASDAQ:VKTX) from a market perform rating to an outperform rating in a research note published on Friday, BenzingaRatingsTable reports. They current

Read more

Watching some historical volatility numbers on shares of Viking Therapeutics, Inc. (NasdaqCM:VKTX), we can see that the 12 month volatility is presently 105.809900. The 6 month volatility is 76.315200

Read more

There are various types of investment philosophies that investors may choose to follow when approaching the stock market. Value investing involves searching for undervalued or bargain stocks that may

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank